Wegovy vs Ozempic: Same Drug, Different Label
Both are semaglutide from the same manufacturer. What separates them is the approved indication, the maximum dose, and how your insurance treats them.
Medically reviewed by Dr. Adaeze Nwosu, MD
People arrive at this question expecting a comparison of two medications. There is only one medication. Wegovy and Ozempic are both semaglutide, both made by Novo Nordisk, and both delivered as a weekly injection.
What actually differs
The approved indication is the real distinction. Ozempic is approved to treat type 2 diabetes. Wegovy is approved for chronic weight management in adults who meet the BMI criteria, and separately for reducing cardiovascular events in adults with established heart disease who are overweight or obese.
The maximum dose also differs. Ozempic tops out at 2.0 mg weekly. Wegovy goes to 2.4 mg. That gap is small but it is the dose the weight-management trials were built on.
- Same active molecule, same manufacturer, same weekly injection.
- Ozempic is labelled for type 2 diabetes, Wegovy for weight management.
- Ozempic maxes at 2.0 mg, Wegovy at 2.4 mg.
- They are packaged differently and priced differently.
Why the label matters more than the molecule
Insurance is the practical reason this distinction exists in your life. Many plans cover Ozempic for a diabetes diagnosis and refuse Wegovy for weight, or cover Wegovy only after documented attempts at lifestyle change. The chemistry is irrelevant to that decision. The billing code is not.
Prescribing Ozempic for weight loss is off-label. That is legal and common, but it changes how coverage is adjudicated and it is a conversation your clinician should have with you openly rather than quietly.
Which one to ask for
If you have type 2 diabetes, Ozempic is usually the straightforward route and the one most likely to be covered.
If you are treating weight without diabetes, Wegovy is the on-label choice and the higher ceiling gives your clinician more room. Whether you can get it depends almost entirely on your plan.
The question worth asking is not which molecule is better. It is which one your insurer will pay for at the dose you actually need.
Where compounded semaglutide sits
Compounded semaglutide is the same molecule prepared by a licensed pharmacy rather than by Novo Nordisk. It is substantially cheaper and it is not an FDA-approved finished product. That regulatory difference is real and worth understanding before you choose on price alone.
We wrote a separate piece on exactly that trade-off, because it deserves more than a paragraph.
This article is for general information and is not medical advice. Talk to a licensed clinician about your own situation before starting or stopping any medication.
